| Jason Cotterill, | |
|
2776 Cleveland Ave, Fort Myers, FL 33901-5864 | |
| (239) 343-2000 | |
| Not Available |
| Full Name | Jason Cotterill |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology Assistant |
| Experience | 5 Years |
| Location | 2776 Cleveland Ave, Fort Myers, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477103927 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | (* (Not Available)) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Josephs Hospital | Tampa, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bay Area Anesthesia Llc | 1153385612 | 37 |
News Archive
Smile Brands Inc., the nation's leading provider of business support services to dental groups in the United States, today announced the grand opening of its newest Castle Dental office in Houston – the 36th office in the Houston area.
Early adolescence is a high-risk period for alcohol experimentation and initiation. Adolescent drinking is linked to exposure to alcohol use in the media.
The University of Texas Health Science Center at Houston (UTHealth) Medical School, in partnership with Memorial Hermann-Texas Medical Center, has unveiled the country's first Mobile Stroke Unit.
Spherix Incorporated, an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that it will explore triglycerides as a potential therapeutic opportunity for its D-tagatose therapy, pending a review of data from a Phase 3 clinical trial the Company is conducting on the use of D-tagatose as a treatment for Type 2 diabetes.
A study led by Zachary Mainen, Director of the Champalimaud Neuroscience Programme, and published today (March 28th) in the scientific journal, Neuron, reports that when rats were challenged with a series of perceptual decision problems.
› Verified 1 days ago
| Entity Name | Us Anesthesia Partners Of Florida Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518910520 PECOS PAC ID: 0345143152 Enrollment ID: O20040129000594 |
News Archive
Smile Brands Inc., the nation's leading provider of business support services to dental groups in the United States, today announced the grand opening of its newest Castle Dental office in Houston – the 36th office in the Houston area.
Early adolescence is a high-risk period for alcohol experimentation and initiation. Adolescent drinking is linked to exposure to alcohol use in the media.
The University of Texas Health Science Center at Houston (UTHealth) Medical School, in partnership with Memorial Hermann-Texas Medical Center, has unveiled the country's first Mobile Stroke Unit.
Spherix Incorporated, an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that it will explore triglycerides as a potential therapeutic opportunity for its D-tagatose therapy, pending a review of data from a Phase 3 clinical trial the Company is conducting on the use of D-tagatose as a treatment for Type 2 diabetes.
A study led by Zachary Mainen, Director of the Champalimaud Neuroscience Programme, and published today (March 28th) in the scientific journal, Neuron, reports that when rats were challenged with a series of perceptual decision problems.
› Verified 1 days ago
| Entity Name | Bay Area Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134210040 PECOS PAC ID: 1153385612 Enrollment ID: O20041115000607 |
News Archive
Smile Brands Inc., the nation's leading provider of business support services to dental groups in the United States, today announced the grand opening of its newest Castle Dental office in Houston – the 36th office in the Houston area.
Early adolescence is a high-risk period for alcohol experimentation and initiation. Adolescent drinking is linked to exposure to alcohol use in the media.
The University of Texas Health Science Center at Houston (UTHealth) Medical School, in partnership with Memorial Hermann-Texas Medical Center, has unveiled the country's first Mobile Stroke Unit.
Spherix Incorporated, an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that it will explore triglycerides as a potential therapeutic opportunity for its D-tagatose therapy, pending a review of data from a Phase 3 clinical trial the Company is conducting on the use of D-tagatose as a treatment for Type 2 diabetes.
A study led by Zachary Mainen, Director of the Champalimaud Neuroscience Programme, and published today (March 28th) in the scientific journal, Neuron, reports that when rats were challenged with a series of perceptual decision problems.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jason Cotterill, 1904 E Louisiana Ave, Tampa, FL 33610-6041 Ph: () - | Jason Cotterill, 2776 Cleveland Ave, Fort Myers, FL 33901-5864 Ph: (239) 343-2000 |
News Archive
Smile Brands Inc., the nation's leading provider of business support services to dental groups in the United States, today announced the grand opening of its newest Castle Dental office in Houston – the 36th office in the Houston area.
Early adolescence is a high-risk period for alcohol experimentation and initiation. Adolescent drinking is linked to exposure to alcohol use in the media.
The University of Texas Health Science Center at Houston (UTHealth) Medical School, in partnership with Memorial Hermann-Texas Medical Center, has unveiled the country's first Mobile Stroke Unit.
Spherix Incorporated, an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that it will explore triglycerides as a potential therapeutic opportunity for its D-tagatose therapy, pending a review of data from a Phase 3 clinical trial the Company is conducting on the use of D-tagatose as a treatment for Type 2 diabetes.
A study led by Zachary Mainen, Director of the Champalimaud Neuroscience Programme, and published today (March 28th) in the scientific journal, Neuron, reports that when rats were challenged with a series of perceptual decision problems.
› Verified 1 days ago
Felicia Nicole Reeves, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 2776 Cleveland Ave, Fort Myers, FL 33901 Phone: 954-759-1985 | |
Morgan Victoria Gloster, CAA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 2776 Cleveland Ave, Fort Myers, FL 33901 Phone: 239-343-2000 | |
Katelyn Van De Water, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 2776 Cleveland Ave, Fort Myers, FL 33901 Phone: 239-343-2000 | |
Bruna Gomes Marciante, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 2776 Cleveland Ave, Fort Myers, FL 33901 Phone: 407-667-0444 | |
Steven Zombory, CAA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 2776 Cleveland Ave, Fort Myers, FL 33901 Phone: 239-343-2000 | |
Vanessa Ordonez, AA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 4048 Evans Ave, Ste 303, Fort Myers, FL 33901 Phone: 239-332-5344 Fax: 239-332-7246 | |
Benjamin Howard Lippitt, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 9981 S Healthpark Dr, Fort Myers, FL 33908 Phone: 239-343-5000 |